[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f3rkh3ki1932b6":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":34,"exclusivities":35,"paragraphIv":36,"catalysts":38},"FIRAZYR","ICATIBANT ACETATE","TAKEDA PHARMS USA","takeda-pharms-usa",[20],"022150","none",1,0,[25],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"022150-001","001","INJECTABLE","SUBCUTANEOUS","EQ 30MG BASE\u002F3ML (EQ 10MG BASE\u002FML)","2011-08-25","AP","RX",[],[],{"asOf":12,"firstFiled":12,"entries":37},[],[]]